GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

A clinical trial led by an Indiana University School of Medicine researcher found that weekly doses of semaglutide - a ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

Geneva: The World Health Organization (WHO) has issued a global safety alert highlighting the risk of non-arteritic anterior ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Nearly 150 new Florida laws went into effect July 1 and some of them make big changes you need to know. Here's the list.

Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Pharmacy benefit leaders at ...

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and ...